Sort   by:  
 Page size 
UnknownDemographic differences among patients treated with chimeric antigen receptor T-cell therapy in the United States.
Not available
S-EPMC9741965 | biostudies-literature
UnknownNovel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome.
Not available
S-EPMC5319562 | biostudies-literature
UnknownMonosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome.
Not available
S-EPMC4790415 | biostudies-literature
UnknownTrends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma.
Not available
S-EPMC9358787 | biostudies-literature
UnknownCurrent Updates on the Management of AL Amyloidosis.
Not available
S-EPMC8425803 | biostudies-literature
UnknownInfection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019.
Not available
S-EPMC8233183 | biostudies-literature
UnknownA Phase I Study to Evaluate Two Doses of Wharton's Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host Disease.
Not available
S-EPMC9289888 | biostudies-literature
UnknownRandomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies.
Not available
S-EPMC8797487 | biostudies-literature
UnknownTargeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study.
Not available
S-EPMC10587711 | biostudies-literature
UnknownDaratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.
Not available
S-EPMC9007985 | biostudies-literature
Sort   by:  
 Page size